doi: 10.1038/nrm.2017.95 263
Managing Side Effects Over Long-Term Use Side effects are the number one concern for anyone thinking about taking anything for an extended period, and it is a fair concern
Because of their B cell properties, some hybridoma clones continually synthesize and secrete a single, genetically homogeneous type of antibody, the monoclonal antibody
It helps find issues like slow growth or excess growth, often due to a pituitary problem
Data from commercial health insurance (not workers compensation) includes that in 2024, about 34% of employers provided coverage for GLP-1 drugs for both diabetes and weight loss, up from 26% in 2023 (Employers Covering GLP-q Drugs in Health Plans Could Nearly Double in 2024, 2023)
Adjusting to Patient Responses Adjustments to the treatment regimen should be made based on ongoing monitoring of patient responses